25 results
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
product or drug candidate, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
424B3
qhdm6hirv32
4 Apr 23
Prospectus supplement
4:57pm
POS AM
1n17 ff84hl8b
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
424B4
5txxdl9ir75
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
uga9 vqhil7sq5
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
9vg418yoezl w73cwb5
2 Jun 21
Draft registration statement
12:00am
DRS
EX-1.1
tqgsc0t uj
2 Jun 21
Draft registration statement
12:00am
10-K
xjim8rd15qnx9
31 Mar 21
Annual report
2:14pm
424B4
uaeanan5 lwdwipaoez
28 Dec 20
Prospectus supplement with pricing info
6:04am